PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,986,000 | -14.9% | 90,906 | +3.1% | 0.30% | -59.3% |
| Q3 2017 | $10,563,000 | +109.0% | 88,205 | +312.1% | 0.73% | +131.0% |
| Q1 2015 | $5,053,000 | +59.6% | 21,402 | +27.9% | 0.32% | +59.6% |
| Q4 2014 | $3,167,000 | -5.6% | 16,733 | +18.9% | 0.20% | -5.7% |
| Q3 2014 | $3,356,000 | +295.8% | 14,069 | +9.6% | 0.21% | +320.0% |
| Q2 2014 | $848,000 | -75.1% | 12,841 | -60.7% | 0.05% | -82.2% |
| Q1 2014 | $3,399,000 | – | 32,646 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |